> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest FDA Warning Letters
- URL: https://www.fdaweb.com/latest-fda-warning-letters-11/
- Published: 2020-02-18T12:00:00.000Z
- Updated: 2026-09-14T16:03:33.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5146113

FDA has posted its latest batch of Warning Letters that includes one medical product company. It can be accessed by clicking on the link following the summary below:

**R-Garden**, Redmond, WA (2/5): FDA inspected the company 8/2019 and cited serious GMP violations for its dietary supplements. For example, R-Garden failed to establish and follow written procedures for the responsibilities of the quality control operations, including written procedures for conducting a material review and making a disposition decision. The company also failed to establish specifications for dietary supplement labels. Additionally, an agency review of product labels/labeling found company claims that make products unapproved new drugs because they are intended for use in the cure, mitigation, treatment, or prevention of disease. To view the letter, click [here](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/r-garden-llc-591065-02052020?ref=fdaweb.com).